Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 9Peutz-Jeghers Syndrome 3Exocrine Pancreatic Insufficiency 2Pancreatic Intraductal Neoplasms 1Intraductal Papillary Mucinous Neoplasms 1Hereditary pancreatitis 1Hereditary Sensory and Autonomic Neuropathies 1Fanconi Anemia, Complementation Group D1 1Dysplastic Nevus Syndrome 1Diabetes Mellitus 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Breast Neoplasms 1

Interventions

Secretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraductal Papillary Mucinous Neoplasms × Secretin × Clear all
NCT00621556 2009-01-29

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Massachusetts General Hospital

Phase 1 Terminated
2 enrolled

Intraductal Papillary Mucinous Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡